{
  "actions": [
    {
      "acted_at": "2010-12-17",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2010-12-17",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr6543-111",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "111",
  "cosponsors": [
    {
      "bioguide_id": "P000034",
      "district": "6",
      "name": "Pallone, Frank, Jr.",
      "original_cosponsor": true,
      "sponsored_at": "2010-12-17",
      "state": "NJ",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001045",
      "district": "1",
      "name": "Stupak, Bart",
      "original_cosponsor": true,
      "sponsored_at": "2010-12-17",
      "state": "MI",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "W000215",
      "district": "30",
      "name": "Waxman, Henry A.",
      "original_cosponsor": true,
      "sponsored_at": "2010-12-17",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2010-12-17",
  "number": "6543",
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Drug Safety Enhancement Act of 2011",
  "sponsor": {
    "bioguide_id": "D000355",
    "district": "15",
    "name": "Dingell, John D.",
    "state": "MI",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2010-12-17",
  "subjects": [
    "Administrative law and regulatory procedures",
    "Administrative remedies",
    "Business records",
    "Civil actions and liability",
    "Criminal procedure and sentencing",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Employment discrimination and employee rights",
    "Evidence and witnesses",
    "Executive agency funding and structure",
    "Government information and archives",
    "Government studies and investigations",
    "Health",
    "Jurisdiction and venue",
    "Licensing and registrations",
    "Manufacturing",
    "Trade restrictions",
    "User charges and fees"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2010-12-17",
    "date": "2011-01-26T18:23:26Z",
    "text": "Drug Safety Enhancement Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to expand safety and inspection requirements for the manufacture and importation\u00a0of drugs by: (1) expanding registration requirements for foreign and domestic drug producers; (2) requiring drug manufacturers to have in effect and implement an effective quality system; (3) expanding and equalizing inspection requirements for foreign and domestic drug producers; (4) imposing additional requirements relating to the notification, nondistribution, and recall of adulterated or misbranded drugs; (5) permitting the detention of drugs found to be in violation of drug safety requirements; (6) allowing for the destruction of drugs that pose a significant adverse health effect; (7) providing enhanced civil and criminal penalties and forfeiture for violations of drug safety requirements and enhanced subpoena authority for investigating violations; (8) prohibiting the importation of drugs into the United States lacking documentation of safety; (9) requiring unique identification numbers for drug establishments and importers; and (10) expanding protections for whistleblowers who refuse to violate, or who disclose violations of, this Act."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Drug Safety Enhancement Act of 2011",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Drug Safety Enhancement Act of 2011",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:21:12Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/111/hr/BILLSTATUS-111hr6543.xml"
}